Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies

Abroad (travel likely)Recruiting

Conditions

Alzheimer's Disease · Dementia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Banner Alzheimer's Institute, Phoenix, Arizona, United States
Contact: Principal Investigator (Jessica Langbaum, PhD)

Study leads

Jessica Langbaum, PhD
Principal Investigator
Banner Alzheimer's Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

InRAD Observational Study

Alzheimer's Disease(AD) · Mild Cognitive Impairment (MCI) · Subjective Cognitive Decline (SCD)

Abroad (travel likely)Recruiting

Schwarzach, Austria · Leuven, Belgium

Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function

Subjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) Dementia

Abroad (travel likely)RecruitingPHASE3

Wuhan, China · Shanghai, China

Virtual Darkness Theraphy for Agitation in Dementia

Agitation in Dementia, Including Alzheimer's Disease

Abroad (travel likely)Recruiting

Askøy, Norway

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

Psychosis Associated With Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE3

Homewood, United States · Phoenix, United States